Inventor · disambiguated record
David Gearing
Also filed as: GEARING DAVID · GEARING DAVID P · GEARING DAVID PAUL
26 granted patents·27 pending applications·549 citations·filing 1988–2019
97Inventor score
Top patents by PatentIndex Score
53 records- 0193US5262522AReceptor for oncostatin M and leukemia inhibitory factorIMMUNEX CORP·Filed 1991·Granted Nov 16, 1993·114 cites·9 claims
- 0292US9580496B2Therapeutic canine immunoglobulins and methods of using sameGEARING DAVID·Filed 2012·Granted Feb 28, 2017·18 cites·11 claims
- 0389US7897725B2Delta3 (tango24) protein and nucleic acid molecules and uses thereofMILLENNIUM PHARM INC·Filed 2007·Granted Mar 1, 2011·7 cites·11 claims
- 0489US6121045AHuman Delta3 nucleic acid moleculesMILLENNIUM BIOTHERAPEUTICS INC·Filed 1997·Granted Sep 19, 2000·90 cites·21 claims
- 0589US5187077ALeukaemia inhibitory factorAMRAD CORP LTD·Filed 1988·Granted Feb 16, 1993·34 cites·7 claims
- 0686US9328164B2Anti-nerve growth factor antibodies and methods of preparing and using the sameGEARING DAVID·Filed 2012·Granted May 3, 2016·9 cites·19 claims
- 0786US5426048ADNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factorIMMUNEX CORP·Filed 1993·Granted Jun 20, 1995·72 cites·7 claims
- 0879US10040849B2Caninized anti-nerve growth factor antibodiesGEARING DAVID·Filed 2012·Granted Aug 7, 2018·4 cites·1 claims
- 0976US5427925ARecombniant method for making leukemia inhibitor factorAMRAD CORP LTD·Filed 1993·Granted Jun 27, 1995·22 cites·22 claims
- 1075US5284755ADNA encoding leukemia inhibitory factor receptorsIMMUNEX CORP·Filed 1992·Granted Feb 8, 1994·23 cites·16 claims
- 1174US5420247ALeukemia inhibitory factor receptors and fusion proteinsIMMUNEX CORP·Filed 1993·Granted May 30, 1995·23 cites·6 claims
- 1273US6391586B1Nucleic acid molecules encoding a secreted neural adhesion proteinMILLENNIUM PHARM INC·Filed 2000·Granted May 21, 2002·1 cites·18 claims
- 1371US6074841ADon-1 gene and polypeptides and uses thereforMILLENNIUM BIOTHERAPEUTICS INC·Filed 1996·Granted Jun 13, 2000·25 cites·30 claims
- 1471US2020207861A1Method of inhibition of leukemic stem cellsCSL LTD·Filed 2019·Application pending·0 cites
- 1569US2015152185A1Method of inhibition of leukemic stem cellsCSL LTD·Filed 2014·Application pending·0 cites
- 1667US5443825AHuman leukemia inhibitory factorAMRAD CORP LTD·Filed 1992·Granted Aug 22, 1995·13 cites·11 claims
- 1765US5629283AGranulocyte-macrophage colony-stimulating factor receptor and derivatives thereofAMRAD CORP LTD·Filed 1994·Granted May 13, 1997·29 cites·12 claims
- 1865US2011052574A1Method of inhibition of leukemic stem cellsCSL LTD·Filed 2008·Application pending·0 cites
- 1964US5952171AMethod for identifying genes encoding secreted or membrane-associated proteinsMILLENNIUM BIOTHERAPEUTICS INC·Filed 1996·Granted Sep 14, 1999·21 cites·4 claims
- 2064US5750654ALeukaemia inhibitory factorAMRAD CORP LTD·Filed 1995·Granted May 12, 1998·13 cites·6 claims
- 2162US7803564B2EGF-like nucleic acids and polypeptides and uses thereofMILLENNIUM PHARM INC·Filed 2007·Granted Sep 28, 2010·0 cites·18 claims
- 2262US2013316343A1Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereofMILLENIUM THE TAKEDA ONCOLOGY COMPANY·Filed 2013·Application pending·0 cites
- 2361US9731007B2Tumour necrosis factor receptor fusion proteins and methods of using the sameNEXVET AUSTRALIA PTY LTD·Filed 2013·Granted Aug 15, 2017·2 cites·14 claims
- 2461US7294482B2EGF-like nucleic acidsMILLENNIUM PHARM INC·Filed 2003·Granted Nov 13, 2007·0 cites·35 claims
- 2561US6395872B1Secreted neural adhesion proteinsMILLENNIUM PHARM INC·Filed 2001·Granted May 28, 2002·0 cites·8 claims
- 2661US2004265970A1Don-1 gene and polypeptides and uses thereforMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 2761US2008293077A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other usesMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2860US6261548B1Leukaemia inhibitory factorAMRAD CORP LTD·Filed 1997·Granted Jul 17, 2001·10 cites·6 claims
- 2959US2013230510A1Method of inhibition of leukemic stem cellsCSL LTD·Filed 2012·Application pending·0 cites
- 3059US2003125540A1Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other usesMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3158US2017029515A1Method of inhibition of leukemic stem cellsCSL LTD·Filed 2016·Application pending·0 cites
- 3257US2006122373A1Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereofMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3355US2018079818A1Method of inhibition of leukemic stem cellsDICK JOHN EDGAR·Filed 2017·Application pending·0 cites
- 3453US2011306044A1Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereofMCCARTHY SEAN A·Filed 2011·Application pending·0 cites
- 3552US2017369565A1Therapeutic canine immunoglobulins and methods of using sameGEARING DAVID·Filed 2017·Application pending·0 cites
- 3651US5726036AGranulocyte-macrophage colony-stimulating factor receptor and derivatives thereofAMRAD CORP LTD·Filed 1995·Granted Mar 10, 1998·5 cites·22 claims
- 3751US2019161540A1Anti-nerve growth factor antibodies and methods of preparing and using the sameNEXVET AUSTRALIA PTY LTD·Filed 2018·Application pending·0 cites
- 3851US2003180784A1Novel human Delta3 compositions and therapeutic and diagnostic uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3948US2014170136A1Anti-nerve growth factor antibodies and methods of preparing and using the sameGEARING DAVID·Filed 2012·Application pending·0 cites
- 4047US6136957AAntibodies which bind granulocyte-macrophane colony-stimulating factor receptorAMRAD CORP LTD·Filed 1997·Granted Oct 24, 2000·8 cites·9 claims
- 4147US2002127594A1Don-1 gene and polypeptides and uses thereforFiled 2002·Application pending·0 cites
- 4247US2002160446A1Novel genes encoding proteins having prognostic diagnostic preventive therapeutic and other usesFiled 2001·Application pending·0 cites
- 4346US2019276525A1Anti-nerve growth factor antibodies and methods of preparing and using the sameNEXVET AUSTRALIA PTY LTD·Filed 2018·Application pending·0 cites
- 4446US2003082677A1Novel EDIRF, MTR-1, LSP-1, TAP-1, and PA-I molecules and uses thereforFiled 2001·Application pending·0 cites
- 4544US2003004098A1Leukaemia inhibitory factorFiled 2001·Application pending·0 cites
- 4642US2014294819A1Canine/feline cd20 binding epitope and compositions for binding theretoNVIP PTY LTD·Filed 2012·Application pending·0 cites
- 4741US2014328838A1Caninised antibodies and method for production of sameGEARING DAVID·Filed 2012·Application pending·0 cites
- 4841US2014294815A1Caninised tumour necrosis factor antibodies and methods of using the sameGEARING DAVID·Filed 2012·Application pending·0 cites
- 4940US6133423ADon-1 gene and polypeptides and uses thereforMILLENNIUM PHARM INC·Filed 1999·Granted Oct 17, 2000·4 cites·13 claims
- 5039US5785967AAntibodies immunoreactive with leukemia inhibitory factor receptorsIMMUNEX CORP·Filed 1994·Granted Jul 28, 1998·2 cites·8 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →